You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Immunogenicity of the third and fourth BNT162b2 mRNA COVID-19 boosters and factors associated with immune response in patients with SLE and rheumatoid arthritis

Citation Tools

Article menu
Epidemiology and outcomes
Original research
Immunogenicity of the third and fourth BNT162b2 mRNA COVID-19 boosters and factors associated with immune response in patients with SLE and rheumatoid arthritis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Assawasaksakul T, Sathitratanacheewin S, Vichaiwattana P, et al
Immunogenicity of the third and fourth BNT162b2 mRNA COVID-19 boosters and factors associated with immune response in patients with SLE and rheumatoid arthritis
Lupus Science & Medicine 2022;9:e000726. doi: 10.1136/lupus-2022-000726